PLRX קפיטליזציה חשבונאית Pliant Therapeutics Inc

Pliant Therapeutics (PLRX) is developing methods to combat tissue scarring, securing long-term leadership through patent protection. This price chart confirms the market status of the company, which currently has a market capitalization of 0.15. High-quality clinical data regarding lung treatment distinguishes the business from its peers, while colossal expenditures on research and safety create an insurmountable barrier for new entrants.

Book value reflects the difference between all assets and liabilities, allowing an investor to filter out speculative noise and identify the real value of business resources through the level of book equity. For Pliant Therapeutics (PLRX), this indicator confirms the financial stability necessary to execute a costly strategy for developing innovative drugs that block tissue scarring in pulmonary fibrosis.